Wolverine Trading, LLC Seelos Therapeutics, Inc. Put Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.59 - $1.04 $4,071 - $7,176
-6,900 Reduced 34.5%
13,100 $9,000
Q4 2022

Feb 14, 2023
SELL
$0.66 - $259.46 $11,022 - $4.33 Million
-16,700 Reduced 45.5%
20,000 $14,000
Q3 2022

Nov 14, 2022
BUY
$0.65 - $278.68 $23,855 - $10.2 Million
36,700 New
36,700 $39,000
Q3 2021

Nov 12, 2021
SELL
$1.69 - $2.89 $17,407 - $29,767
-10,300 Closed
0 $0
Q2 2021

Aug 06, 2021
BUY
$2.64 - $6.32 $27,192 - $65,096
10,300 New
10,300 $27,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0
View Full List

About SEELOS THERAPEUTICS, INC.

SEEL Quotes by TradingView
  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $32M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email